среда, 28 сентября 2016 г.

Eli Lilly and Co. (LLY) Upgraded to "Buy" at Zacks Investment Research

Eli Lilly and Co. (LLY) Upgraded to "Buy" at Zacks Investment Research


The firm presently has a $89.00 price target on the stock. Zacks Investment Research's target price suggests a potential upside of 10.04% from the company's current price.



from Biotech News